Serum leptin and tumor necrosis factor – alpha levels and maximal exercise performance in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008
Levels of plasma tumour necrosis factor and soluble tumour necrosis factor receptor in patients with COPD and its relation to glucocorticoid receptor levels Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Surges in circulating interleukin-6 and transforming growth factor-β associated with exercise in patients with COPD are attenuated by pulmonary rehabilitation Source: Annual Congress 2009 - Exploring outcome measures in COPD and pulmonary rehabilitation Year: 2009
The use of tumor necrosis factor alpha inhibitor pentoxifylline in the treatment of patients with I and II stages of pulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 542s Year: 2006
Influence of tobacco-smoking on serum level of transforming growth factor (TGF) beta 1 in COPD patients Source: International Congress 2017 – COPD biomarkers Year: 2017
Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006
CPAP decreases elevated plasma levels of soluble tumor necrosis factor-α receptor 1 in OSAS patients Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008
Association of the TNF gene promoter polymorphism with serum tumor necrosis factor-alpha levels in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 522s Year: 2006
Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001
Arterial concentration of macrophage migration inhibitory factor (MIF) increases with exercise in patients with pulmonary hypertension (PH) Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010
Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients Source: Eur Respir J 2007; 30: 701-707 Year: 2007
Low plasma stem cell factor combined with high transforming growth factor-a identifies high-risk patients in pulmonary arterial hypertension Source: ERJ Open Res, 4 (4) 00035-2018; 10.1183/23120541.00035-2018 Year: 2018
Changes of alveolar oxygen tension in chronic obstructive pulmonary disease (COPD) and effect of variable oxygen tension on hypoxia inducible factor (HIF)-1alpha system of alveolar epithelial cells Source: Annual Congress 2013 –COPD: experimental biology Year: 2013
Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial Source: Eur Respir J 2014; 43: 295-298 Year: 2004
Oxygen desaturation is associated with fibrocyte activation via epidermal growth factor receptor/hypoxia-inducible factor(HIF)-1a axis in COPD Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019
Sputum tumour necrosis factorα (TNFα) levels in steroid dependent asthma (SDA) compared with COPD and normal controls Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001
Measurement of tumor necrosis factor (TNF)α, leukotriene B4 (LTB4), and interleukin 8 (IL8) in the exhaled breath condensate (EBC) in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Use of interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1Ra) contents in alveolar macrophages for estimation of inflammation activity in patients with different levels of asthma control Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012